MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: rituximab
Drug: cyclophosphamide
Drug: dexamethasone
Drug: lenalidomide

First Posted Date: 2008-11-04

Last Posted Date: 2016-10-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 36

Registration Number: NCT00784927

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Predictive Genetic Risk Assessment Trial

Completed

Conditions: Colon Cancer
Lung Cancer
Atrial Fibrillation
Diabetes Type 2
Obesity
Breast Cancer
Graves Disease
Osteoarthritis
Celiac Disease
Myocardial Infarction

Interventions: Genetic: SNP analysis

First Posted Date: 2008-10-31

Last Posted Date: 2011-04-27

Lead Sponsor: Mayo Clinic

Target Recruit Count: 26

Registration Number: NCT00782366

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery

Completed

Conditions: Breast Cancer

First Posted Date: 2008-10-21

Last Posted Date: 2012-01-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 98

Registration Number: NCT00776308

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

Interventions: Drug: dexamethasone
Drug: lenalidomide

First Posted Date: 2008-10-15

Last Posted Date: 2020-01-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 39

Registration Number: NCT00772915

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy

Phase 4

Completed

Conditions: Renal Calculus
Kidney Stones

Interventions: Drug: Placebo
Drug: Ketorolac

First Posted Date: 2008-10-02

Last Posted Date: 2012-01-27

Lead Sponsor: Mayo Clinic

Target Recruit Count: 17

Registration Number: NCT00765128

Locations: 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States

Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy

Phase 4

Completed

Conditions: Nephrectomy
Laparoscopic Donor Nephrectomy

Interventions: Drug: Placebo
Drug: Ketorolac

First Posted Date: 2008-10-02

Last Posted Date: 2012-01-27

Lead Sponsor: Mayo Clinic

Target Recruit Count: 111

Registration Number: NCT00765232

Locations: 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Early Phase 1

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2008-09-23

Last Posted Date: 2017-10-31

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT00757549

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1

Phase 2

Completed

Conditions: Neurofibromatosis

First Posted Date: 2008-09-18

Last Posted Date: 2012-03-19

Lead Sponsor: Mayo Clinic

Target Recruit Count: 24

Registration Number: NCT00754780

Transfusion-Induced Alterations of Pulmonary and Immune Function in Mechanically Ventilated Patients

Not Applicable

Completed

Conditions: Pulmonary Edemas
Blood Protein Disorders

Interventions: Other: RBC transfusion of conventional storage age
Other: RBC transfusion of 5 days or less storage age

First Posted Date: 2008-09-11

Last Posted Date: 2012-01-31

Lead Sponsor: Mayo Clinic

Target Recruit Count: 100

Registration Number: NCT00751322

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer

Early Phase 1

Completed

Conditions: Breast Cancer
Lymphedema

First Posted Date: 2008-08-28

Last Posted Date: 2018-10-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT00743314

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy